🇬🇧 Iressa in United Kingdom

Iressa (gefitinib) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Local brand name: Gefitinib Mylan
  • Status: approved

Iressa in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United Kingdom

Frequently asked questions

Is Iressa approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Iressa in United Kingdom?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.